Costa Rican cyclist Andrey Amador moves into third place in the Giro d’Italia
Cyclist Andrey Amador made history Saturday after moving into third place in the Giro d’Italia, the highest ranking ever achieved by a Costa Rican. The Giro d’Italia is the second most prestigious cycling race, following the Tour de France. Amador, 28, began riding professionally in 2006 and is the only Costa Rican to have ever competed in the Tour de France.
Amador, a member of the Movistar cycling team, jumped from 8th to 3rd place after placing 15th in the 14th stage of the tour, a 59.4-kilometer time trial race. Despite pouring rain, Amador managed to secure a personal best time of 1:19:40, just 1:48 behind the stage’s leader, the Belarusian Vasil Kiryienka. The Costa Rican now sits just 3’36” behind the race’s leader, legendary Spanish cyclist Alberto Contador.
Watch Amador in the 14th stage of the Giro d’Italia
“I was able to do well today, but the important thing is that I got to where I am now,” Amador told Costa Rican daily La Nación after his big finish. “There are tough mountainous days ahead and that is going to be difficult, but I am motivated and want to keep fighting to see how far we can get.”
There are seven stages remaining in the Giro d’Italia, the last of which will be held in Torino on May 31.
Related: Tough finish for Tico Olympians
You may be interested
Morning-after pill can now be sold without a prescription in Costa RicaAlejandro Zúñiga - May 18, 2019
Levonorgestrel, marketed commercially as "Plan B" and commonly known as the morning-after pill, can legally be sold without a prescription…
Pic of the Day: A busy day in San JoséThe Tico Times - May 18, 2019
Costa Rica wants to reorganize its chaotic transport system and start decarbonizing its economy with a modern electric train through…
MINAE raises alarm about drug trafficking in Costa Rica’s protected landRita Valverde / Semanario Universidad - May 17, 2019
The Environment and Energy Ministry (MINAE) has requested assistance from the Public Security Ministry in the face of increased drug…